NELSON SONJA (Chief Fin. & Operating Officer) received a stock award from AMBRX BIOPHARMA CAYMAN, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/28/2023ACC: 0001209191-23-026101
Officer· Chief Fin. & Operating Officer
Since Jan 2023
+1M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
1M acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+1M
Price / share
—
Trade value
—
% of position
New position
4/26/2023
0.00→1M
Total
Net shares
+1M
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/26/2023 | A · Award | +1M | — | — | New position | 0.00 | 1M |
| Total | +1M | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported